News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

European Commission Announces Public Hearing on Phthalates in Medical Devices

General
27
February 2024
•
490
Dr Steven Brennan
Interested participants are required to register by the 17 March, 2024, with the event operating on a first-come, first-served basis due to limited space.
Medical devices on a table
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The European Commission's dedication to public health safety takes a significant step forward with the announcement of a public hearing by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER). Scheduled for the 11 April, 2024, this event aims to address the presence of phthalates in certain medical devices, focusing on updating guidelines related to their benefit-risk assessment.

Public Consultation and Hearing Details

The hearing is part of a broader public consultation process, open from 27 March to 28 April 2024, allowing for a comprehensive collection of comments, suggestions, and scientific inputs on the guidelines. This initiative showcases the Commission's commitment to evidence-based policymaking and stakeholder engagement in health and safety regulations.

The Significance of Phthalates

Phthalates, known for their flexibility-enhancing properties, are widely used in various products, including medical devices. Given their potential health risks, such as carcinogenic and endocrine-disrupting effects, their use in medical settings is being re-evaluated, leading to the need for updated safety guidelines.

Scientific Discussion and Participation

The Brussels hearing will serve as a platform for scientists and technical experts to discuss scientific evidence concerning phthalates in medical devices. Emphasizing a scientific approach, the Commission has stated that the event will focus solely on scientific matters, explicitly prohibiting public relations or lobbying efforts.

Registration and Attendance

Interested participants are required to register by the 17 March, 2024, with the event operating on a first-come, first-served basis due to limited space. The Commission has advised against making travel or accommodation arrangements until participation is confirmed, noting that it will not cover any related expenses.

Conclusion and Further Information

This public hearing represents a key moment in the European Commission's efforts to ensure the highest health and safety standards for its citizens. It underscores the importance of scientific inquiry and public involvement in addressing emerging health risks. The final program and list of participants will be made available on the Scientific Committees' website, offering further insight into the event's objectives and significance.

For those invested in the regulatory landscape of medical devices and public health policy, the SCHEER public hearing on 11 April 2024, is a pivotal event marking the European Commission's proactive stance on health and safety concerns.

Read the source story

The European Commission's dedication to public health safety takes a significant step forward with the announcement of a public hearing by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER). Scheduled for the 11 April, 2024, this event aims to address the presence of phthalates in certain medical devices, focusing on updating guidelines related to their benefit-risk assessment.

Public Consultation and Hearing Details

The hearing is part of a broader public consultation process, open from 27 March to 28 April 2024, allowing for a comprehensive collection of comments, suggestions, and scientific inputs on the guidelines. This initiative showcases the Commission's commitment to evidence-based policymaking and stakeholder engagement in health and safety regulations.

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

EU parliamentEU Water Resilience Strategy Gains Momentum as MEPs Demand PFAS Phase-Out and Digital Upgrades

May 9, 2025

Chemicals productionEU Chemical Industry Faces Weak Q1 2025 as Energy Costs Undermine Competitiveness

May 9, 2025

EU ParliamentENVI Committee Pushes EU PFAS Ban Forward with Strong Political Backing

May 2, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

EU parliament

EU Water Resilience Strategy Gains Momentum as MEPs Demand PFAS Phase-Out and Digital Upgrades

MEPs back the EU Water Resilience Strategy, calling for PFAS phase-out, digital solutions, and funding—key compliance watchpoints for industry.

9

May 2025

General
Chemicals production

EU Chemical Industry Faces Weak Q1 2025 as Energy Costs Undermine Competitiveness

EU chemical industry struggles in Q1 2025 as energy costs and weak demand hinder growth. Find out what this means for your value chain.

9

May 2025

General
UK parliament

UK Government Unveils Major Regulatory Reform to Boost Growth

The UK Government is cutting business compliance costs by 25% through regulatory reforms in manufacturing, chemicals, and infrastructure.

2

May 2025

General
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy